1-8 of 8
Silvia Buttignol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients

Francesca Gay, MD, Federica Cavallo, Tommaso Caravita, MD, Maide Cavalli, Arnon Nagler, MD, MSc, Vittorio Montefusco, MD, Enrico Maria Pogliani, MD, Silvia Buttignol, MD, Elena Zamagni, MD, Carmela Palladino, Magda Marcatti, MD, Pellegrino Musto, MD, Lucio Catalano, Anna Baraldi, MD, Angelo Michele Carella, MD, Anna Maria Cafro, MD, Agostina Siniscalchi, MD, Claudia Crippa, MD, Letizia Maria Vallone, Giovannino Ciccone, Dina Ben Yehuda, Francesco Di Raimondo, MD, Izhar Hardan, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2089.
https://doi.org/10.1182/blood.V122.21.2089.2089
Published: 2013
Journal Articles

Clinical Factors Predictive Of Myelofibrotic Evolutions In Patients With Essential Thrombocythemia and Polycythemia Vera

Mario Tiribelli, MD, Federico De Marchi, MD, Daniela Barraco, MD, Luciana Marin, MD, Erika Codarin, PhD, Silvia Buttignol, MD, Daniela Damiani, MD, Renato Fanin, MD
Journal: Blood
Blood (2013) 122 (21): 4082.
https://doi.org/10.1182/blood.V122.21.4082.4082
Published: 2013
Journal Articles

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation

Clinical Trials & Observations
Elena Zamagni, Francesca Patriarca, Cristina Nanni, Beatrice Zannetti, Emanuela Englaro, Annalisa Pezzi, Paola Tacchetti, Silvia Buttignol, Giulia Perrone, Annamaria Brioli, Lucia Pantani, Carolina Terragna, Francesca Carobolante, Michele Baccarani, Renato Fanin, Stefano Fanti, Michele Cavo
Journal: Blood
Blood (2011) 118 (23): 5989–5995.
https://doi.org/10.1182/blood-2011-06-361386
Published: 2011
Journal Articles

Conventionally-Defined and PET/CT-Defined Complete Response (CR) to Novel Agent-Based Induction Therapy and Autologous Stem-Cell Transplantation (ASCT) In Multiple Myeloma (MM): A Prospective Study of Clinical and Prognostic Implications

Elena Zamagni, MD, Cristina Nanni, MD, Francesca Patriarca, MD, Annalisa Pezzi, Statistician, Beatrice Anna Zannetti, MD, Paola Tacchetti, MD, Emanuela Englaro, MD, Giulia Perrone, MD, Silvia Buttignol, MD, Annamaria Brioli, MD, Lucia Pantani, MD, Francesca Carobolante, MD, Michele Baccarani, MD, Stefano Fanti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 826.
https://doi.org/10.1182/blood.V118.21.826.826
Published: 2011
Journal Articles

Prognostic Relevance of 18F-FDG PET/CT In Newly Diagnosed Multiple Myeloma Patients Treated with up-Front Autologous Transplantation: A Prospective Study

Elena Zamagni, Cristina Nanni, Francesca Patriarca, Paola Tacchetti, Emanuela Englaro, Giulia Perrone, Silvia Buttignol, Annamaria Brioli, Lucia Pantani, Beatrice Anna Zannetti, Francesca Caroborante, Michele Baccarani, Stefano Fanti, Michele Cavo
Journal: Blood
Blood (2010) 116 (21): 369.
https://doi.org/10.1182/blood.V116.21.369.369
Published: 2010
Journal Articles

Bortezomib-Thalidomide-Dexamethasone Compared with Thalidomide-Dexamethasone as Induction and Consolidation Therapy Before and After Double Autologous Transplantation In Newly Diagnosed Multiple Myeloma: Results From a Randomized Phase 3 Study

Michele Cavo, Giulia Perrone, Silvia Buttignol, Elisabetta Calabrese, Monica Galli, Sara Bringhen, Tonino Spadano, Luca Baldini, Tommaso Caravita, Chiara Nozzoli, Annamaria Brioli, Luciano Masini, Anna Furlan, Lucia Pantani, Daniele Derudas, Stelvio Ballanti, Francesco Pisani, Valerio De Stefano, Gioacchino Catania, Luca Castagna, Felicetto Ferrara, Vincenzo Callea, Pellegrino Musto, Elena Zamagni, Michele Baccarani
Journal: Blood
Blood (2010) 116 (21): 42.
https://doi.org/10.1182/blood.V116.21.42.42
Published: 2010
Journal Articles

Clinical Outcomes According to Genomic Abnormalities in 566 Newly Diagnosed Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.

Michele Cavo, M.D., Sara Bringhen, M.D., Nicoletta Testoni, B.S., Paola Omedè, B.S., Giulia Marzocchi, B.S., Marina Ruggeri, B.S., Sandra Durante, B.S., Francesco Di Raimondo, M.D., Davide Rossi, M.D., Ausilia Gorgone, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Massimo Offidani, M.D., Chiara Nozzoli, M.D., Roberto Ria, M.D., Barbara Olivero, M.D., Monica Galli, M.D., Vittorio Montefusco, M.D., Vincenzo Callea, M.D., Antonietta Falcone, M.D., Antonio De Vivo, M.D., Mario Boccadoro, MD, Carolina Terragna, B.S., Antonio Palumbo, M.D.
Journal: Blood
Blood (2009) 114 (22): 1868.
https://doi.org/10.1182/blood.V114.22.1868.1868
Published: 2009
Journal Articles

Superior Complete Response Rate and Progression-Free Survival after Autologous Transplantation with up-Front Velcade-Thalidomide- Dexamethasone Compared with Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Franco Narni, M.D., Sara Bringhen, M.D., Vittorio Montefusco, M.D., Massimo Offidani, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Ausilia Gorgone, M.D., Annamaria Brioli, M.D., Maria Caterina Pallotti, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Antonio Ledda, M.D., Tommaso Caravita, M.D., Antonietta Falcone, M.D., Alfonso Zaccaria, M.D., Giulia Perrone, M.D., Alessandro Petrucci, M.D., Antonio Palumbo, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 158.
https://doi.org/10.1182/blood.V112.11.158.158
Published: 2008